(Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -92.47%-194.3K | 99.25%-5.65K | 26.86%-139.64K | 26.93%-1.44M | 68.53%-394.02K | -111.19%-100.95K | -793.86%-757.38K | 87.60%-190.93K | 51.45%-1.98M | 10.14%-1.25M |
Net income from continuing operations | -80.86%-308.15K | 82.40%-89.99K | 95.05%-140.29K | 28.44%-8.29M | 41.96%-4.77M | -72.21%-170.38K | 55.50%-511.41K | -34.08%-2.84M | -87.17%-11.58M | -156.96%-8.22M |
Operating gains losses | ---- | ---- | ---- | -103.78%-1.04K | -103.05%-864 | ---176 | ---- | ---- | --27.5K | --28.28K |
Depreciation and amortization | -78.08%5.73K | -7.22%24.06K | -7.52%24.06K | -57.66%104.17K | -34.20%26.11K | -35.49%26.12K | -63.14%25.93K | -72.76%26.01K | -23.58%246K | -63.31%39.67K |
Asset impairment expenditure | --3.19K | --0 | --3.38K | -86.10%172.27K | -85.41%172.27K | --0 | --0 | --0 | -9.12%1.24M | -13.40%1.18M |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --735.79K | --0 |
Remuneration paid in stock | --0 | --0 | --0 | -98.00%15.96K | -19,441.27%-2.37M | -98.99%1.8K | -97.37%9.93K | -93.04%15.96K | 85.70%797.25K | -92.94%12.26K |
Deferred tax | ---- | ---- | ---- | -12.66%-24.76K | ---- | ---- | ---- | ---- | 6.40%-21.97K | ---- |
Other non cashItems | 6,470.83%34.69K | 90.09%15.67K | -99.48%12.39K | 9.78%6.8M | 19.84%6.78M | -99.90%528 | -33.44%8.25K | 14,537.60%2.37M | 4,022.96%6.19M | 26,669.77%5.66M |
Change In working capital | 70.63%70.24K | 115.38%44.61K | -116.47%-39.19K | -157.03%-221.89K | -420.07%-210.95K | -84.92%41.16K | -152.56%-290.07K | 147.42%237.96K | 419.43%389.05K | -59.26%65.91K |
-Change in receivables | 239.87%103.35K | -107.00%-39.84K | 85.06%-8.35K | -369.09%-72.96K | -136.53%-28.2K | -39.68%30.41K | -120.09%-19.25K | 71.51%-55.92K | 142.00%27.11K | 6,693.17%77.21K |
-Change in inventory | 33.69%4.48K | -51.45%3.72K | -101.70%-1.03K | -83.56%39.19K | -144.92%-32.16K | -95.30%3.35K | -95.69%7.67K | 173.15%60.33K | 177.63%238.35K | 161.81%71.59K |
-Change in prepaid assets | 1,427.91%17.13K | 978.40%58.07K | -180.27%-58.72K | 366.61%80.23K | -97.27%2.98K | -100.86%-1.29K | -96.35%5.39K | 118.82%73.15K | -90.11%17.19K | 30.70%108.94K |
-Change in payables and accrued expense | -729.53%-54.73K | 107.98%22.66K | -81.97%28.91K | -352.21%-268.34K | 19.95%-153.56K | 379.48%8.69K | -317.22%-283.88K | -3.21%160.4K | 40.25%106.4K | -198.16%-191.83K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -92.47%-194.3K | 99.25%-5.65K | 26.86%-139.64K | 26.93%-1.44M | 68.53%-394.02K | -111.19%-100.95K | -793.86%-757.38K | 87.60%-190.93K | 51.45%-1.98M | 10.14%-1.25M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 6,205.84%317.93K | 503.58%195.89K | -109.34%-2.36K | -26.77%15.34K | 3,896.10%109.06K | 99.29%-5.21K | 80.25%-48.54K |
Net PPE purchase and sale | --0 | ---- | ---- | 44.27%26.07K | 52.39%27.88K | ---1.82K | ---- | ---- | 112.78%18.07K | 367.91%18.3K |
Net business purchase and sale | --0 | --0 | --0 | 13,290.26%266.6K | 827.28%169.27K | -107.12%-1.8K | ---9.93K | --109.06K | -88.30%1.99K | -18.64%-23.27K |
Net other investing changes | ---- | ---- | ---- | 200.00%25.27K | 97.11%-1.26K | --1.26K | 38.08%25.27K | ---- | ---25.27K | ---43.56K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | --0 | 6,205.84%317.93K | 503.58%195.89K | -109.34%-2.36K | -26.77%15.34K | 3,896.10%109.06K | 99.29%-5.21K | 80.25%-48.54K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 81.21%100K | -84.63%100.11K | 66.32%162.55K | -37.62%971.23K | -56.15%167.18K | -43.53%55.19K | 929.01%651.14K | -90.37%97.73K | -41.50%1.56M | -79.07%381.26K |
Net issuance payments of debt | 81.21%100K | -27.32%100.11K | 66.32%162.55K | 235.84%457.83K | 127.02%167.18K | -43.53%55.19K | 117.66%137.73K | 223.25%97.73K | -27.35%-337.03K | -609.20%-618.74K |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 0.00%1M | ---- |
Proceeds from stock option exercised by employees | --0 | --0 | ---- | -42.57%513.4K | ---1 | --0 | --513.41K | ---- | 8.94%894K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 81.21%100K | -84.63%100.11K | 66.32%162.55K | -37.62%971.23K | -56.15%167.18K | -43.53%55.19K | 929.01%651.14K | -90.37%97.73K | -41.50%1.56M | -79.07%381.26K |
Net cash flow | ||||||||||
Beginning cash position | 27.58%173.5K | -64.91%80.02K | -73.36%57.71K | -66.55%216.6K | -92.50%85.36K | 20.98%135.99K | 95.26%228.03K | -66.55%216.6K | -76.82%647.49K | 141.57%1.14M |
Current changes in cash | -95.96%-94.3K | 203.91%94.46K | 44.40%22.91K | 63.59%-154.11K | 96.63%-30.95K | -104.69%-48.12K | -17,620.47%-90.91K | 103.00%15.87K | 80.22%-423.29K | -603.61%-919.53K |
Effect of exchange rate changes | 68.01%-802 | 13.30%-984 | 86.52%-598 | 37.05%-4.78K | 323.02%3.29K | -5,930.23%-2.51K | 70.67%-1.14K | -93.33%-4.44K | -26.40%-7.6K | 75.43%-1.48K |
End cash Position | -8.15%78.4K | 27.58%173.5K | -64.91%80.02K | -73.36%57.71K | -73.36%57.71K | -92.50%85.36K | 20.98%135.99K | 95.26%228.03K | -66.55%216.6K | -66.55%216.6K |
Free cash from | -89.07%-194.3K | 99.25%-5.65K | 26.86%-139.64K | 26.84%-1.45M | 68.53%-394.02K | -111.39%-102.77K | -793.86%-757.38K | 87.63%-190.93K | 59.01%-1.98M | 22.68%-1.25M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data